首页> 外文OA文献 >Recurrence of mitral valve regurgitation after mitral valve repair in degenerative valve disease. Reply to Myerson SG
【2h】

Recurrence of mitral valve regurgitation after mitral valve repair in degenerative valve disease. Reply to Myerson SG

机译:二尖瓣修复后的二尖瓣返流在变性瓣膜疾病中的复发。回复Myerson SG

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

BACKGROUND: Durability assessment of mitral valve repair for degenerative valve incompetence is actually limited to reoperation as the primary indicator, with valve-related risk factors for late death as a secondary indicator. We assessed serial echocardiographic follow-up of valve function as an indicator of the durability of mitral valve repair. METHODS AND RESULTS: In 242 patients who had undergone mitral valve repair for degenerative valve incompetence, echocardiographic follow-up of valve function, rate of reoperation, survival, and clinical outcome was studied. At 8 years after repair, clinical outcome was excellent, survival was 90.9+/-3.2%, freedom from reoperation was 94.2+/-2.3%, and freedom from anticoagulation bleeding and thromboembolic events was 90.4+/-2.7%. However, freedom from non-trivial mitral regurgitation (>1/4) was 94.3+/-1.6% at 1 month, 58.6+/-4.9% at 5 years, and 27.2+/-8.6% at 7 years. Freedom from severe mitral regurgitation (>2/4) was 98.3+/-0.9% at 1 month, 82.8+/-3.8% at 5 years and 71.1+/-7.4% at 7 years. The linearized recurrence rate of non-trivial mitral regurgitation (>1/4) was 8.3% per year and of severe mitral regurgitation (>2/4) was 3.7% per year. Inadequate surgical techniques (chordal shortening, no use of annuloplasty ring or sliding plasty) could only partially explain recurrence of regurgitation. In selected patients who did not have these risk factors, linearized recurrence rates were 6.9% per year and 2.5% per year, respectively. CONCLUSIONS: The durability of a successful mitral reconstruction for degenerative mitral valve disease is not constant, and this should be taken into account when asymptomatic patients are offered early mitral valve repair.
机译:背景:二尖瓣修复退化性瓣膜功能不全的耐久性评估实际上仅限于再次手术作为主要指标,而瓣膜相关的晚期死亡危险因素则作为辅助指标。我们评估了瓣膜功能的连续超声心动图随访,作为二尖瓣修复的持久性指标。方法和结果:在242例因瓣膜退化性二尖瓣修复而接受二尖瓣修复的患者中,研究了超声心动图随访的瓣膜功能,再次手术率,生存率和临床结局。修复后8年的临床结果非常好,生存率为90.9 +/- 3.2%,再次手术的自由度为94.2 +/- 2.3%,免受抗凝性出血和血栓栓塞事件的自由度为90.4 +/- 2.7%。但是,二月非平凡反流(> 1/4)的自由度在1个月时为94.3 +/- 1.6%,在5年时为58.6 +/- 4.9%,在7年时为27.2 +/- 8.6%。严重二尖瓣反流(> 2/4)在1个月时为98.3 +/- 0.9%,在5年时为82.8 +/- 3.8%,在7年时为71.1 +/- 7.4%。非平凡二尖瓣反流(> 1/4)的线性化复发率为每年8.3%,严重二尖瓣反流(> 2/4)的线性复发率为每年3.7%。手术技术不足(和弦缩短,不使用瓣环成形术或滑动成形术)只能部分解释反流的复发。在没有这些危险因素的特定患者中,线性化复发率分别为每年6.9%和每年2.5%。结论:对于退化性二尖瓣疾病,成功的二尖瓣重建术的持久性不是恒定不变的,当为无症状患者提供早期二尖瓣修复时,应考虑到这一点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号